Total Return chart Ligand Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-24 EDT			After hours 19:56:00
300.53 ^USD	-0.54%		235.78	-21.55%

07-15	RBC Capital Adjusts Price Target on Ligand Pharmaceuticals to $340 From $262, Maintains Outperform Rating	MT
07-14	Ligand Pharmaceuticals Incorporated completed the acquisition of XOMA Royalty Corporation from a group of shareholders.	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.

2007-04-02

2.5 USD